| Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials M Merabishvili, JP Pirnay, G Verbeken, N Chanishvili, M Tediashvili, ... PloS one 4 (3), e4944, 2009 | 585 | 2009 |
| The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure? JP Pirnay, D De Vos, G Verbeken, M Merabishvili, N Chanishvili, ... Pharmaceutical research 28, 934-937, 2011 | 325 | 2011 |
| Experimental phage therapy of burn wound infection: difficult first steps T Rose, G Verbeken, D De Vos, M Merabishvili, M Vaneechoutte, ... International journal of burns and trauma 4 (2), 66, 2014 | 246 | 2014 |
| Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury—a case report S Jennes, M Merabishvili, P Soentjens, KW Pang, T Rose, E Keersebilck, ... Critical Care 21, 1-3, 2017 | 238 | 2017 |
| Quality and safety requirements for sustainable phage therapy products JP Pirnay, BG Blasdel, L Bretaudeau, A Buckling, N Chanishvili, JR Clark, ... Pharmaceutical research 32, 2173-2179, 2015 | 238 | 2015 |
| Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages JD Van Belleghem, F Clement, M Merabishvili, R Lavigne, ... Scientific reports 7 (1), 8004, 2017 | 197 | 2017 |
| Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review S Uyttebroek, B Chen, J Onsea, F Ruythooren, Y Debaveye, D Devolder, ... The Lancet Infectious Diseases 22 (8), e208-e220, 2022 | 154 | 2022 |
| Expert opinion on three phage therapy related topics: bacterial phage resistance, phage training and prophages in bacterial production strains C Rohde, G Resch, JP Pirnay, BG Blasdel, L Debarbieux, D Gelman, ... Viruses 10 (4), 178, 2018 | 137 | 2018 |
| Stability of Staphylococcus aureus phage ISP after freeze-drying (lyophilization) M Merabishvili, C Vervaet, JP Pirnay, D De Vos, G Verbeken, J Mast, ... PloS one 8 (7), e68797, 2013 | 127 | 2013 |
| Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii M Merabishvili, D Vandenheuvel, AM Kropinski, J Mast, D De Vos, ... PloS one 9 (8), e104853, 2014 | 121 | 2014 |
| Bacteriophage application for difficult-to-treat musculoskeletal infections: development of a standardized multidisciplinary treatment protocol J Onsea, P Soentjens, S Djebara, M Merabishvili, M Depypere, I Spriet, ... Viruses 11 (10), 891, 2019 | 119 | 2019 |
| Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae A Eskenazi, C Lood, J Wubbolts, M Hites, N Balarjishvili, L Leshkasheli, ... Nature Communications 13 (1), 302, 2022 | 118 | 2022 |
| European regulatory conundrum of phage therapy G Verbeken, D De Vos, M Vaneechoutte, M Merabishvili, M Zizi, JP Pirnay Future Medicine Ltd 2 (5), 485-491, 2007 | 113 | 2007 |
| Microbiological and Molecular Assessment of Bacteriophage ISP for the Control of Staphylococcus aureus K Vandersteegen, W Mattheus, PJ Ceyssens, F Bilocq, D De Vos, ... PLoS One 6 (9), e24418, 2011 | 109 | 2011 |
| Introducing yesterday’s phage therapy in today’s medicine JP Pirnay, G Verbeken, T Rose, S Jennes, M Zizi, I Huys, R Lavigne, ... Future Virology 7 (4), 379-390, 2012 | 106 | 2012 |
| Guidelines to compose an ideal bacteriophage cocktail M Merabishvili, JP Pirnay, D De Vos Bacteriophage Therapy: From Lab to Clinical Practice, 99-110, 2018 | 94 | 2018 |
| Pre‐adapting parasitic phages to a pathogen leads to increased pathogen clearance and lowered resistance evolution with Pseudomonas aeruginosa cystic … VP Friman, D Soanes‐Brown, P Sierocinski, S Molin, HK Johansen, ... Journal of evolutionary biology 29 (1), 188-198, 2016 | 91 | 2016 |
| A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient D Lebeaux, M Merabishvili, E Caudron, D Lannoy, L Van Simaey, ... Viruses 13 (1), 60, 2021 | 88 | 2021 |
| Strategy for Identification of Bacillus cereus and Bacillus thuringiensis Strains Closely Related to Bacillus anthracis D Daffonchio, N Raddadi, M Merabishvili, A Cherif, L Carmagnola, ... Applied and environmental microbiology 72 (2), 1295-1301, 2006 | 86 | 2006 |
| Phenotypic and genotypic variations within a single bacteriophage species PJ Ceyssens, T Glonti, M Kropinski, R Lavigne, N Chanishvili, L Kulakov, ... Virology journal 8, 1-5, 2011 | 82 | 2011 |
